CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
Not yet recruiting · NCT06470841 · Registry updated 2024-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 2 | 2024-08-22 | NCT06470841 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Navy General Hospital, Beijing | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Navy General Hospital | Beijing | China | 9 |